NCT01395017 2016-04-08LAPCOtsuka Pharmaceutical Development & Commercialization, Inc.Phase 2 Completed202 enrolled 9 charts
NCT00474812 2015-05-05Dasatinib in Treating Patients With Metastatic Pancreatic CancerNational Cancer Institute (NCI)Phase 2 Completed51 enrolled 10 charts